$XMTR

Rollins Emily sold $422K of XMTR

Rollins Emily sold 5,000 shares of Xometry, Inc. (XMTR) at an average of $84.31 ($83.61–$85.47, $0.42M total) across 3 trades on 2026-08-19 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Rollins Emily
Published Aug 21, 2026, 8:28 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 8:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$XMTR
Bearish
medium confidence
Mentioned
$XMTR
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$XMTRBearishLow
01

Why it matters

The disclosed sale provides fresh data for traders monitoring insider activity.

02

Market read

Insider sale adds modest negative sentiment but limited market impact.

03

What to watch

Director may be diversifying holdings; no change in company fundamentals.

Relevance 3/10Novelty 4/10Timing: post-market 2026-08-19

Background

Form 4 filings disclose insider transactions; a director's sale is publicly reported.

Company-level read

Ticker impact

$XMTRBearishMedium confidence
Context

Director Rollins Emily sold 5,000 shares for $421.5K via a 10b5-1 plan, reducing her stake to 15,136 shares.

Expected impact

Possible modest downward pressure in the next trading session.

Evidence & confidence

Sale size is modest relative to market cap, but director-level insider activity often influences sentiment.

Market effects

Minimal impact on the broader manufacturing services sector.

Limited to U.S. markets where Xometry trades.

Low

Counterpoint

The sale could be routine liquidity planning under a 10b5-1, not a negative signal.

Key entities

  • Rollins Emily

    Director of Xometry who sold shares.

  • Xometry, Inc.

    Provider of on-demand manufacturing services.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$XMTRMedAI 8/10

Six Montgomery County companies attract more than $566 million in capital investment – WTOP News

Six Montgomery County companies raised over $566 million in Q3. Forbright (Nasdaq) completed an IPO, raising $142.2 million. Xometry (Nasdaq) announced a $225 million secondary offering. RegenxBio (Nasdaq) raised $90.04 million in a public offering. Georgiamune secured $92.69 million in venture funding. Arculus Solutions raised $1.95 million in Seed-1 funding. Jesse & Ben raised $15 million in Series A funding.

$XMTRHighAI 9/10

Xometry (XMTR) Q2 2026 Earnings Call Transcript

Xometry (XMTR) reported Q2 2026 revenue of $229.3 million, up 41% year over year, with marketplace revenue of $215.4 million (+45%). Adjusted EBITDA was $14.1 million, and non-GAAP net income was $9.9 million. The company raised Q3 2026 revenue guidance to $234 million to $236 million and full-year 2026 revenue growth to 33% to 34%.

$XMTRMed

Xometry, Inc. Q2 2026 Earnings Call Summary

Xometry, Inc. reported Q2 2026 results and said revenue growth accelerated for a fourth straight quarter, driven by a product-led shift toward an AI ecosystem. It cited improved CNC cost prediction accuracy (+~15%), record 175 net new enterprise accounts over $50,000, and reduced ad spend to 3.4% of revenue. Full-year 2026 revenue growth guidance raised to 33%-34% and marketplace gross margin target 35%-40%. Cash was $517M after a $248M follow-on and $50M Siemens investment.

$XMTRHighAI 9/10

Xometry, Inc.: Xometry Reports Record Second Quarter 2026 Results

Xometry (NASDAQ: XMTR) reported Q2 2026 results: revenue rose 41% to $229 million, with marketplace revenue up 45% to $215 million. Gross profit increased 34% to $87.2 million and Adjusted EBITDA rose $10.2 million to $14.1 million. Cash and equivalents were $517 million after a June equity offering. Q3 guidance calls for $234-$236 million revenue and $16-$17 million Adjusted EBITDA.